Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avoid ‘Ugly Confrontation’ With Inward Looking US, Indian Firms Ask Govt

Executive Summary

Leading Indian firms have sought a conciliatory approach as the Indian government deals with the Trump administration in the US, against a backdrop of concerns over possible new protectionist tax measures that could impede Indian drug exports.

Advertisement

Related Content

Indian Firms’ US Revenues Slow Sharply But Balance Sheets Still Solid
IDMA Meet: Trump, Protectionism, New Markets And Cricket
US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen
Will 'Businessman' Trump See The Value In Indian Generics?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120156

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel